We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Distinct targeting and uptake of platelet and red blood cell‐derived extracellular vesicles into immune cells
Summary
This study examined how tiny vesicles (small bubble-like particles) released by platelets and red blood cells interact with immune cells. Platelet-derived vesicles were taken up by certain immune cells much faster than red blood cell vesicles, and neither type affected T-cells. While not directly about microplastics, the research is relevant because it helps scientists understand how small particles in the blood, including nanoplastics, might interact with the immune system.
Blood-derived extracellular vesicles (EVs) hold great therapeutic potential. As blood contains mixed EV populations, it is challenging to study EVs originating from different cells separately. Blood cell concentrates manufactured in blood banks offer an excellent non-invasive source of blood cell-specific EV populations. To study blood cell-specific EVs, we isolated EVs from platelet (TREVs) and red blood cell (EryEVs) concentrates and characterized them using nanoparticle tracking analysis, imaging flow cytometry, electron microscopy and western blot analysis and co-cultured them with peripheral blood mononuclear cells (PBMCs). Our aim was to use imaging flow cytometry to investigate EV interaction with PBMCs as well as study their effects on T-lymphocyte populations to better understand their possible biological functions. As a conclusion, TREVs interacted with PBMCs more than EryEVs. Distinctively, TREVs were uptaken into CD11c+ monocytes rapidly and into CD19+ B-lymphocytes in 24 h. EryEVs were not uptaken into CD11c+ monocytes before the 24-h time point, and they were only seen on the surface of lymphocytes. Neither TREVs nor EryEV were uptaken into CD3+ T-lymphocytes and no effect on T-cell populations was detected. We have previously seen similar differences in targeting PC-3 cancer cells. Further studies are needed to address the functional properties of blood cell concentrate-derived EVs. This study demonstrates that imaging flow cytometry can be used to study the distinctive differences in the interaction and uptake of EVs. Considering our current and previous results, EVs present a new valuable component for the future development of blood-derived therapeutics.
Sign in to start a discussion.
More Papers Like This
Detrimental effects of micro- and nanoplastics (MNPs) on platelet and neutrophil immunity: Recent findings and emerging insights
Researchers reviewed how micro- and nanoplastics (MNPs) harm the immune system, finding that tiny plastic particles can trigger dangerous inflammation in platelets and neutrophils — immune cells that control clotting and infection defense. These effects could disrupt normal blood vessel function and immune balance, though the exact mechanisms by which cells take up MNPs remain poorly understood.
Platelet Immune Interactions, Lifespan, and Senescence
This review examines the role platelets play in immune responses, including their interactions with pathogens and their behavior during autoimmune conditions. While not directly focused on microplastics, the study explores how activated platelets show shortened lifespans and early aging in various diseases, which is relevant context for understanding how foreign particles may affect blood components. The findings inform the development of new therapeutic approaches targeting platelet-immune interactions.
The impact of micro- and nanoplastics on immune system development and functions: Current knowledge and future directions
This review summarizes existing research on how micro- and nanoplastics affect the immune system, finding that exposure can disrupt blood cell development, alter immune cell behavior, and trigger inflammatory responses in lab and animal studies. While some studies show significant effects on organs like the spleen and intestines, others found minimal impact at environmentally realistic exposure levels, highlighting the need for more standardized research.
Journey of micronanoplastics with blood components
This study provides the first comprehensive assessment of how micro- and nanoplastics interact with blood components after entering the human bloodstream. Researchers found that these particles can cause protein damage, red blood cell destruction, immune system activation, and blood clotting abnormalities. The findings highlight that microplastics in the bloodstream may pose a range of health risks beyond the organs where they initially enter the body.
Divergent responses of human erythrocytes to nano-, micro-, and size-mixed polystyrene particles reveal distinct cellular effects of environmental plastics
Researchers examined how different sizes of polystyrene particles affect human red blood cells in laboratory conditions. The study found that 100-nanometer particles caused shape changes in red blood cells consistent with membrane interaction, while 1-micrometer particles showed minimal effects. Notably, when both sizes were combined, they triggered cell aggregation, demonstrating that size-mixed plastic particles can produce distinct effects not seen with individual sizes alone.